Volume 28, Number 7—July 2022
Dispatch
Multisystem Inflammatory Syndrome after Breakthrough SARS-CoV-2 Infection in 2 Immunized Adolescents, United States
Table 2
Infectious laboratory results for 2 adolescents after multisystem inflammatory syndrome in children symptom onset and throughout hospitalization, United States*
Laboratory test | Case-patient 1 | Case-patient 2 |
---|---|---|
SARS-CoV-2 spike IgG | Positive | NA |
SARS-CoV-2 nucleocapsid IgG | Positive | Positive |
SARS-CoV-2 PCR | Negative | Positive† |
Other respiratory pathogen panel PCR | Negative | Negative |
Blood culture, peripheral, 2 sets | Negative | Negative |
Urine culture | Negative | Negative |
Epstein Barr virus ab panel | Consistent with prior infection | Negative |
Gastrointestinal pathogen panel PCR | Negative | NA |
Group A Streptococcus throat PCR | Negative | NA |
Quantiferon tuberculosis gold | Negative | NA |
HIV Ag/Ab, 4th-generation | NA | Nonreactive |
Rapid plasma regain | NA | Nonreactive |
Parvovirus IgM and IgG | NA | Negative |
Anti-streptolysin-O | NA | Negative |
Anti-deoxyribonuclease B | NA | Negative |
*Ag, antigen; Ab, antibody. †Case-patient 2 had a positive SARS-CoV-2 PCR result on day-of-illness 11, followed by a negative result on day-of-illness 19.